Table 4.
Within pediatric dermatologists (n=5) | Within pediatric rheumatologists (n=5) | Within pediatric neurologists (n=5) | |
---|---|---|---|
CDASI | |||
Activity | 0.90 (0.78–1.00) | 0.91 (0.79–1.00) | 0.65 (0.29–1.00) |
Damage | 0.97 (0.94–1.00) | 0.64 (0.27–1.00) | 0.78 (0.53–1.00) |
CAT-BM | |||
Activity | 0.86 (0.70–1.00) | 0.88 (0.74–1.00) | 0.91 (0.80–1.00) |
Damage | 0.93 (0.85–1.00) | 0.73 (0.44–1.00) | 0.89 (0.76–1.00) |
Skin PGA | |||
Activity | 0.95 (0.90–1.00) | 0.50 (0.03–0.96) | 0.83 (0.64–1.00) |
Damage | 0.84 (0.66–1.00) | 0.55 (0.12–0.98) | 0.96 (0.91–1.00) |
Intra-class correlation coefficients (95% C.I.)
Abbreviations: CDASI: Cutaneous Dermatomyositis Disease Area and Severity Index; CAT-BM: Cutaneous Assessment Tool-Binary Method; PGA: Physician Global Assessment
Summary: The intra-rater agreement was excellent for pediatric dermatologists using the CDASI and CAT-BM measures, and the intra-rater agreement was good to excellent for pediatric rheumatologists and neurologists using the same outcome instruments.